메뉴 건너뛰기




Volumn 36, Issue 40, 2015, Pages 2677-2680

Gender differences in the effect of cardiovascular drugs: A position document of theworkinggroup on pharmacology and drug therapy of the ESC

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; DIGOXIN; FIBRINOLYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

EID: 84948660878     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehv161     Document Type: Note
Times cited : (150)

References (19)
  • 1
    • 78349271737 scopus 로고    scopus 로고
    • Gender differences in treatment of cardiovascular disease: A task force on gender of the ESC proposal on gender specific studies in cardiovascular pharmacology
    • Rosano GM, Collins P. Gender differences in treatment of cardiovascular disease: a task force on gender of the ESC proposal on gender specific studies in cardiovascular pharmacology. Fundam Clin Pharmacol 2010;24:662-663.
    • (2010) Fundam Clin Pharmacol , vol.24 , pp. 662-663
    • Rosano, G.M.1    Collins, P.2
  • 4
    • 65349137639 scopus 로고    scopus 로고
    • Sex differences in pharmacokinetics and pharmacodynamics
    • Soldin OP, Mattison DR. Sex differences in pharmacokinetics and pharmacodynamics. Clin Pharmacokinet 2009;48:143-157.
    • (2009) Clin Pharmacokinet , vol.48 , pp. 143-157
    • Soldin, O.P.1    Mattison, D.R.2
  • 5
    • 25844458971 scopus 로고    scopus 로고
    • Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases
    • Jochmann N, Stangl K, Garbe E, Baumann G, Stangl V. Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases. Eur Heart J 2005;26:1585-1595.
    • (2005) Eur Heart J , vol.26 , pp. 1585-1595
    • Jochmann, N.1    Stangl, K.2    Garbe, E.3    Baumann, G.4    Stangl, V.5
  • 7
    • 30944467297 scopus 로고    scopus 로고
    • Aspirin for the primary prevention of cardiovascular events in women and men: A sex-specific meta-analysis of randomized controlled trials
    • Berger JS, Roncaglioni MC, Avanzini F, Pangrazzi I, Tognoni G, Brown DL. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA 2006;295:306-313.
    • (2006) JAMA , vol.295 , pp. 306-313
    • Berger, J.S.1    Roncaglioni, M.C.2    Avanzini, F.3    Pangrazzi, I.4    Tognoni, G.5    Brown, D.L.6
  • 8
    • 0037206368 scopus 로고    scopus 로고
    • Sex-based differences in the effect of digoxin for the treatment of heart failure
    • Rathore SS, Wang Y, Krumholz HM. Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med 2002;347:1403-1411.
    • (2002) N Engl J Med , vol.347 , pp. 1403-1411
    • Rathore, S.S.1    Wang, Y.2    Krumholz, H.M.3
  • 9
    • 33749184189 scopus 로고    scopus 로고
    • The anti-ischemic effect of metoprolol in patients with chronic angina pectoris is gender-specific
    • Cocco G, Chu D. The anti-ischemic effect of metoprolol in patients with chronic angina pectoris is gender-specific. Cardiology 2006;106:147-153.
    • (2006) Cardiology , vol.106 , pp. 147-153
    • Cocco, G.1    Chu, D.2
  • 11
    • 0010838455 scopus 로고    scopus 로고
    • Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: A systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group
    • Flather MD, Yusuf S, Kober L, Pfeffer M, Hall A, Murray G, Torp-Pedersen C, Ball S, Pogue J, Moye L, Braunwald E. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group. Lancet 2000;355:1575-1581.
    • (2000) Lancet , vol.355 , pp. 1575-1581
    • Flather, M.D.1    Yusuf, S.2    Kober, L.3    Pfeffer, M.4    Hall, A.5    Murray, G.6    Torp-Pedersen, C.7    Ball, S.8    Pogue, J.9    Moye, L.10    Braunwald, E.11
  • 14
    • 0033517302 scopus 로고    scopus 로고
    • The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators
    • Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999;341:709-717.
    • (1999) N Engl J Med , vol.341 , pp. 709-717
    • Pitt, B.1    Zannad, F.2    Remme, W.J.3    Cody, R.4    Castaigne, A.5    Perez, A.6    Palensky, J.7    Wittes, J.8
  • 15
    • 33750626722 scopus 로고    scopus 로고
    • The effect of gender on the pharmacokinetics of verapamil and norverapamil in human
    • Dadashzadeh S, Javadian B, Sadeghian S. The effect of gender on the pharmacokinetics of verapamil and norverapamil in human. Biopharm Drug Dispos 2006;27:329-334.
    • (2006) Biopharm Drug Dispos , vol.27 , pp. 329-334
    • Dadashzadeh, S.1    Javadian, B.2    Sadeghian, S.3
  • 18
    • 45249083641 scopus 로고    scopus 로고
    • Drug-induced long QT syndrome in women: Review of current evidence and remaining gaps
    • Hreiche R, Morissette P, Turgeon J. Drug-induced long QT syndrome in women: review of current evidence and remaining gaps. Gend Med 2008;5:124-135.
    • (2008) Gend Med , vol.5 , pp. 124-135
    • Hreiche, R.1    Morissette, P.2    Turgeon, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.